PROFOUND MEDICAL CORP (PRN.CA) Stock News

Canada - TSX:PRN - CA74319B5027 - Common Stock

8 CAD

-1.05 (-11.6%)

Last: 10/10/2025, 7:00:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

PRN.CA Latest News, Press Relases and Analysis

All

Press Releases

5 days ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter

5 days ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter

19 days ago - By: Profound Medical Corp. - Mentions: PROF

Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding Access to Advanced Prostate Treatment

2 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical to Participate in Lake Street’s 9th Annual Best Ideas Growth Conference

19 days ago - By: Profound Medical Corp. - Mentions: PROF

Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding Access to Advanced Prostate Treatment

2 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical to Participate in Lake Street’s 9th Annual Best Ideas Growth Conference

2 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical Announces Second Quarter 2025 Financial Results

2 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical Announces Second Quarter 2025 Financial Results

3 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow

3 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow

4 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction

4 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction

4 months ago - By: Profound Medical Corp. - Mentions: PROF

Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO®

4 months ago - By: Profound Medical Corp. - Mentions: PROF

Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO®

5 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical Annual General and Special Meeting of Shareholders Voting Results

5 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical Annual General and Special Meeting of Shareholders Voting Results

5 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical Announces First Quarter 2025 Financial Results

5 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference

5 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference

6 months ago - By: Profound Medical Corp. - Mentions: PROF

Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy

6 months ago - By: Profound Medical Corp. - Mentions: PROF

Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy

6 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical to Release First Quarter 2025 Financial Results on May 8 – Conference Call to Follow

6 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical to Release First Quarter 2025 Financial Results on May 8 – Conference Call to Follow

6 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical AUA 2025 Investor Event Agenda

6 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical AUA 2025 Investor Event Agenda

7 months ago - By: Profound Medical Corp. - Mentions: PROF

Save the Date: Profound Medical to Host Investor Event at AUA 2025

7 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical Announces Fourth Quarter and Full Year 2024 Financial Results

7 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical Announces Fourth Quarter and Full Year 2024 Financial Results

8 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 – Conference Call to Follow

8 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 – Conference Call to Follow

9 months ago - By: Profound Medical Corp. - Mentions: PROF

Update: Profound Medical’s Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th

9 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues

9 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues

9 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference

9 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference

10 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares

10 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares

10 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares

10 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares

10 months ago - By: Profound Medical Corp. - Mentions: PROF

Profound Medical Announces Proposed Public Offering of Common Shares